Identification of Desaturation Episodes by Means of Continuous Measurement of Oxygen Saturation During Hemodialysis
1 other identifier
observational
30
1 country
1
Brief Summary
The clinical diagnosis of sleep apnea is difficult among ESRD patients since the characteristic clinical features of sleep apnea may be absent and since sleep-related symptoms, such as fatigue and sleepiness, may be attributed to kidney failure. However, the evaluation of patients with possible sleep apnea is the same among ESRD patients as in the general population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2016
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2016
CompletedFirst Submitted
Initial submission to the registry
December 6, 2016
CompletedFirst Posted
Study publicly available on registry
December 8, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedDecember 8, 2016
December 1, 2016
3 months
December 6, 2016
December 6, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Identifying Intradialytis desaturation episodes
• To determine the sensitivity and specificity of the CLM for identifying intradialytic desaturation episodes, using the WatchPAT device as the reference method.
1 week
Study Arms (1)
ESRD Patients
The following inclusion criteria must be met for each subject. * Age ≥18 years and able to give written informed consent to the study * On chronic hemodialysis for ≥ 90 days at time of enrollment * Ability to read * Consent to have video recording taken during study visit
Interventions
Collect anthropomorphic, WatchPAT, Crit-line Monitor measurements as well as sleep questionnaires and video records
Eligibility Criteria
Chronic hemodialysis patients
You may qualify if:
- Age ≥18 years and able to give written informed consent to the study
- On chronic hemodialysis for ≥ 90 days at time of enrollment
- Ability to read
- Consent to have video recording taken during study visit
You may not qualify if:
- Subjects with cognitive impairment to consent
- Sickle cell anemia
- Prescription of nasal oxygen
- Simultaneous participation in another clinical trial that may affect breathing frequency/patterns, blood oxygenation, sleep/wake cycle or other parameters related to the outcomes of interest to this study
- Use of a breathing device, e.g. CPAP
- Central venous catheter used as vascular access for hemodialysis
- Artificial fingernails (may disturb the measurement of the WatchPAT)
- Use of one of the following medications: alpha blockers, short acting nitrates (less than 3 hours before the study).
- Permanent pacemaker
- Sustained non-sinus cardiac arrhythmias.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Renal Research Institute
New York, New York, 10065, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 6, 2016
First Posted
December 8, 2016
Study Start
December 1, 2016
Primary Completion
March 1, 2017
Study Completion
December 1, 2017
Last Updated
December 8, 2016
Record last verified: 2016-12